Biblio

Export 1713 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2017
F. Rokad, Moseley, R., Hardy, R. S., Chukkapalli, S., Crean, S. J., Kesavalu, L., and Singhrao, S. K., “Cerebral Oxidative Stress and Microvasculature Defects in TNF-α Expressing Transgenic and Porphyromonas gingivalis-Infected ApoE-/- Mice.”, J Alzheimers Dis, vol. 60, no. 2, pp. 359-369, 2017.
F. Rokad, Moseley, R., Hardy, R. S., Chukkapalli, S., Crean, S. J., Kesavalu, L., and Singhrao, S. K., “Cerebral Oxidative Stress and Microvasculature Defects in TNF-α Expressing Transgenic and Porphyromonas gingivalis-Infected ApoE-/- Mice.”, J Alzheimers Dis, vol. 60, no. 2, pp. 359-369, 2017.
R. Santangelo, Cecchetti, G., Bernasconi, M. Paola, Cardamone, R., Barbieri, A., Pinto, P., Passerini, G., Scomazzoni, F., Comi, G., and Magnani, G., “Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 183-200, 2017.
R. Santangelo, Cecchetti, G., Bernasconi, M. Paola, Cardamone, R., Barbieri, A., Pinto, P., Passerini, G., Scomazzoni, F., Comi, G., and Magnani, G., “Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 183-200, 2017.
R. Santangelo, Cecchetti, G., Bernasconi, M. Paola, Cardamone, R., Barbieri, A., Pinto, P., Passerini, G., Scomazzoni, F., Comi, G., and Magnani, G., “Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 183-200, 2017.
E. Niemantsverdriet, Ottoy, J., Somers, C., De Roeck, E., Struyfs, H., Soetewey, F., Verhaeghe, J., Van den Bossche, T., Van Mossevelde, S., Goeman, J., De Deyn, P. Paul, Mariën, P., Versijpt, J., Sleegers, K., Van Broeckhoven, C., Wyffels, L., Albert, A., Ceyssens, S., Stroobants, S., Staelens, S., Bjerke, M., and Engelborghs, S., “The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 60, no. 2, pp. 561-576, 2017.
G. P. Paraskevas, Kasselimis, D., Kourtidou, E., Constantinides, V., Bougea, A., Potagas, C., Evdokimidis, I., and Kapaki, E., “Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1453-1461, 2017.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H., “Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
E. T. Ighodaro, Nelson, P. T., Kukull, W. A., Schmitt, F. A., Abner, E. L., Caban-Holt, A., Bardach, S. H., Hord, D. C., Glover, C. M., Jicha, G. A., Van Eldik, L. J., Byrd, A. X., and Fernander, A., “Challenges and Considerations Related to Studying Dementia in Blacks/African Americans.”, J Alzheimers Dis, vol. 60, no. 1, pp. 1-10, 2017.
D. P. Devanand, Lentz, C., Chunga, R. E., Ciarleglio, A., Scodes, J. M., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Bell, K., and Pelton, G. H., “Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1525-1531, 2017.
D. P. Devanand, Lentz, C., Chunga, R. E., Ciarleglio, A., Scodes, J. M., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Bell, K., and Pelton, G. H., “Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1525-1531, 2017.
L. Crispoltoni, Stabile, A. Maria, Pistilli, A., Venturelli, M., Cerulli, G., Fonte, C., Smania, N., Schena, F., and Rende, M., “Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1005-1017, 2017.
L. Crispoltoni, Stabile, A. Maria, Pistilli, A., Venturelli, M., Cerulli, G., Fonte, C., Smania, N., Schena, F., and Rende, M., “Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1005-1017, 2017.
S. C. C. Chan, Chan, C. C. H., Derbie, A. Y., Hui, I., Tan, D. G. H., Pang, M. Y. C., Lau, S. C. L., and Fong, K. N. K., “Chinese Calligraphy Writing for Augmenting Attentional Control and Working Memory of Older Adults at Risk of Mild Cognitive Impairment: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 58, no. 3, pp. 735-746, 2017.
S. C. C. Chan, Chan, C. C. H., Derbie, A. Y., Hui, I., Tan, D. G. H., Pang, M. Y. C., Lau, S. C. L., and Fong, K. N. K., “Chinese Calligraphy Writing for Augmenting Attentional Control and Working Memory of Older Adults at Risk of Mild Cognitive Impairment: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 58, no. 3, pp. 735-746, 2017.
M. T. Turnbull and Coulson, E. J., “Cholinergic Basal Forebrain Lesion Decreases Neurotrophin Signaling without Affecting Tau Hyperphosphorylation in Genetically Susceptible Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1141-1154, 2017.
F. Gelfo, Cutuli, D., Nobili, A., De Bartolo, P., D'Amelio, M., Petrosini, L., and Caltagirone, C., “Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1505-1518, 2017.
F. Gelfo, Cutuli, D., Nobili, A., De Bartolo, P., D'Amelio, M., Petrosini, L., and Caltagirone, C., “Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1505-1518, 2017.
S. Villarreal, Zhao, F., Hyde, L. A., Holder, D., Forest, T., Sondey, M., Chen, X., Sur, C., Parker, E. M., and Kennedy, M. E., “Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1393-1413, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C., “Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C., “Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
P. Gareri, Castagna, A., Cotroneo, A. Maria, Putignano, D., Conforti, R., Santamaria, F., Marino, S., and Putignano, S., “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
P. Gareri, Castagna, A., Cotroneo, A. Maria, Putignano, D., Conforti, R., Santamaria, F., Marino, S., and Putignano, S., “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
P. Gareri, Castagna, A., Cotroneo, A. Maria, Putignano, D., Conforti, R., Santamaria, F., Marino, S., and Putignano, S., “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.

Pages